SPI1 and metabolic dysfunction-associated steatohepatitis: applied proteomics strategy to identify SPI1 as critical TF, SPI1 expression was positively related to resistance indicator HOMA-IR and the inflammatory marker TNFA in human liver biopsies, and inhibition of SPI1 ameliorated metabolic dysfunction and NASH (86).